We make the invisible visible
Event Dates: 2022-10-03 to 2022-10-05
FASM and MAX IV warmly invite MAX IV User communities, students, researchers, newly interested persons and collective to the 34th MAX IV User Meeting: “Collaboration in Focus”, 3-5 October 2022, at Scandic Star Hotel, Lund, Sweden. The registration is open during 4 July – 15 September 2022. The 34th MAX IV User Meeting will host several sessions
Researchers from Uppsala University have identified a molecule that can be developed into a drug to treat COVID-19. The molecule was discovered by using structure-based virtual screening and has a strong ability to inhibit both SARS-CoV-2 replication and the previously known variants of the coronavirus. This research was a part of the SciLifeLab and KAW
Image: The chip developed by researchers during the project. Credit: Saketh Ram Mamidala Researchers from Lund University benefitted from MAX IV laboratory to find solutions to the long-standing technological challenge: the von-Neumann bottleneck. After nearly year-long research during the pandemic, they successfully integrated the processor and memory onto a single vertical nanowire in a 3D
Event Dates: 2022-06-13 to 2022-06-14
Welcome to a workshop to update the science case for a Soft X-ray Laser beamline at MAX IV. Venue: AlbaNova University Center, Stockholm, Sweden Date: June 13–14, 2022 Read more and register at: https://indico.maxiv.lu.se/event/5042/
Ganciclovir, a regular medicine used to treat human cytomegalovirus (HCMV) infections, was found less efficient when reacting to human’s NUDT15 enzyme — based on a recent BioMAX study. This finding gives further insight into pharmaceutical treatments’ efficacy in HCMV cases. Although being regarded as a common disease, HCMV infections might cause severe consequences for immunocompromised
Alina Andersson and Buster, the robot dog, during measurements tests done at MicroMAX hutch on Thursday (7/10) MAX IV had a special visitor yesterday (7/10) named Buster; a robot dog produced by Boston Dynamics. It is part of a thesis project between the Survey, Alignment, and Mechanical Stability (SAM) team; led by Alina Andersson, and LTH engineers; Ola Nilsson
The crystal structure of MtMce4A39–140 shows four molecules in asymmetric units. The structure of the substrate-binding mammalian cell entry (Mce)4A protein from Mycobacterium tuberculosis, the causative agent of the disease Tuberculosis, was unknown — until recent research at BioMAX beamline. It showed the unique Mce domain of Mce4A, a part of the cholesterol importing complex of
Researchers used an electron beam derived from MAX IV’s electron gun at the MAXPEEM beamline to break borazine molecules into fragments thus enabling the synthesis of amorphous boron nitride onto an otherwise inert graphene film. The results of the experiment indicate that electron beam-induced deposition of borazine actually impacts its boron nitrogen bonds. This effect
An advanced data analysis platform for the crystallographic fragment screening (CFS) method is available for users and other partners of MAX IV. This web-based data analysis platform facilitates data processing, structure refinement, automated ligand fitting, multi dataset analysis, and even data visualization of CFS method experiments at the BioMAX beamline — bringing CFS project management
Researchers from the Swedish University of Agricultural Sciences (SLU), Alnarp, found that extrusion processing of quinoa grains increased its protein crosslinking and specific fiber type solubility. At the same time, the nanostructure investigated by SAXS and WAXS showed that extrusion processing caused morphological changes in the protein and starch of the extruded quinoa foods. While